Bio


Dr. Adam J. Murrietta is a fellowship-trained orthopaedic surgeon with Stanford Health Care. He is also a clinical assistant professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine.

Dr. Murrietta diagnoses and treats a wide range of bone and joint conditions, including arthritis, bursitis, fractures, and infections. As an orthopaedic surgeon, he specializes in joint replacement surgery, with a focus on hip and knee replacements. He has advanced expertise in minimally invasive techniques, robotic-assisted procedures, and outpatient joint replacement. Additionally, Dr. Murrietta has extensive training in the latest surgical technologies and uses these innovations to reduce pain and enhance outcomes for his patients.

Dr. Murrietta’s research focuses on improving surgical outcomes and the treatment and management of orthopaedic injuries. His ongoing work focuses on joint replacement techniques and patient-reported outcomes. His research has been published in peer-reviewed journals, including The Journal of Arthroplasty, The Bone & Joint Journal, and Journal of the American Academy of Orthopaedic Surgeons. He has also presented his findings at regional and national conferences, including annual meetings of the Western Orthopaedic Association and the American Association of Hip and Knee Surgeons.

Dr. Murrietta is a fellow of the American Association of Hip and Knee Surgeons (AAHKS) and the American Academy of Orthopaedic Surgeons (AAOS). He is also a member of the American Medical Association (AMA) and the Western Orthopaedic Association (WOA).

Clinical Focus


  • Adult Reconstructive Orthopedic Surgery

Academic Appointments


Honors & Awards


  • Resident Research Award, Western Orthopaedic Association
  • Research Fellowship, University of Southern California Keck School of Medicine
  • Outstanding Junior Resident Award, Orthopaedic Surgery, Stanford University School of Medicine
  • Outstanding Consultant Award, Emergency Medicine, Stanford University School of Medicine
  • Outstanding Chief Resident Award, Orthopaedic Surgery, Stanford University School of Medicine
  • Member, Gold Humanism Honor Society, University of Southern California (USC) Keck School of Medicine Chapter
  • Member, Alpha Omega Alpha Honor Medical Society, California Gamma Chapter
  • Administrative Chief Resident, Orthopaedic Surgery, Stanford University School of Medicine

Boards, Advisory Committees, Professional Organizations


  • Member, Western Orthopaedic Association (2022 - Present)
  • Fellow, American Association of Hip and Knee Surgeons (2023 - Present)
  • Member, American Medical Association (2019 - Present)
  • Fellow, American Academy of Orthopaedic Surgeons (2023 - Present)

Professional Education


  • Fellowship: Massachusetts General Hospital Dept of Orthopaedic Surgery (2025) MA
  • Residency: Stanford University Orthopaedic Surgery Residency (2024) CA
  • Medical Education: Keck USC Medical Center Medical Staff Office (2019) CA

All Publications


  • Recommending Surgery Increases Patient Satisfaction with Arthroplasty Surgeons. The Journal of arthroplasty Murrietta, A. J., Bonano, J. C., Finlay, A. K., Huddleston, J. I., Goodman, S. B., Maloney, W. J., Amanatullah, D. F. 2025

    Abstract

    Current guidelines recommend shared decision-making in the treatment of hip and knee osteoarthritis, but the impact of individual treatment decisions on patient satisfaction scores is unknown. We hypothesized that clinic Press Ganey satisfaction ratings would be higher for patients who later underwent arthroplasty than patients who did not have surgery.Press Ganey satisfaction surveys were obtained from all patient visits at a single academic institution's arthroplasty clinic from 2010 to 2018. We identified those patients who went on to have a total joint arthroplasty after shared decision-making. Among 1,133 patients who filled out a Press Ganey survey, 559 (49%) patients underwent surgery, and 574 (51%) patients did not. We then compared differences in provider 5-star ratings and mean star ratings between patients who did or did not have surgery using Chi-square, logistic regression, and t-tests.Patients who had surgery were more likely to give a 5-star rating (75 versus 70%, P = 0.001) and had 62% higher odds of giving a 5-star rating for the likelihood to recommend the provider (odds ratio: 1.62, 95% confidence interval: 1.19 to 2.19, P = 0.001). Each provider received a higher mean star rating from patients who underwent arthroplasty (4.66 ± 0.67) when compared to those who did not receive surgery (4.57 ± 0.80, P = 0.001). Providers who had a higher percentage of their patients receive surgery also had higher overall mean star ratings (P = 0.001).Press Ganey satisfaction scores may be influenced by the decision to pursue operative treatment for hip and knee arthritis. Providers who do not recommend surgery may receive lower satisfaction scores, despite using a shared decision-making approach. Patient satisfaction, therefore, may not be a valid proxy for quality of care in arthroplasty and must be questioned as a quality or reimbursement metric.

    View details for DOI 10.1016/j.arth.2025.01.043

    View details for PubMedID 39884482

  • Primary Total Hip Arthroplasty in Juvenile Idiopathic Arthritis: Survivorship after a Median Follow-up of 12 Years. The Journal of arthroplasty Warren, S. I., Hwang, K. L., Lee, J. J., Murrietta, A., Koltsov, J. C., Goodman, S. B. 2023

    Abstract

    Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition of childhood that frequently affects the hip. Total hip arthroplasty (THA) in JIA can be challenging due to the patient's young age, small proportion, complex anatomy, and bone loss. Outcome data is limited.We reviewed prospectively collected data in 57 JIA patients (83 hips) who underwent THA between 1986 and 2020 by a single surgeon. The median patient age at surgery was 26 years (range, 14 to 62). Reoperation-free survival was assessed via the cumulative incidence function, accounting for the competing risk of death. Relationships between patient and implant factors and survivorship were evaluated by stratification of the cumulative incidence function and Gray's tests. Wilcoxon signed rank tests were used to assess the preoperative to latest postoperative change in patient reported outcomes measures (PROMs).At a median (interquartile range) of 12 (4, 20) years follow-up, 13 (16%) patients underwent reoperation, most commonly for polyethylene wear and osteolysis (7 hips). The estimated incidence of 10-, 20-, and 30-year revision (95% confidence interval) were 11.3% (4.5, 21.6%), 18.5% (8.9, 30.9%), and 40.6% (19.4, 60.9%), respectively. There were no differences in survival based on patient age, sex, implant fixation method, polyethylene type, or thickness. All PROMs improved from preoperative to latest follow up.Primary THA is a durable and effective treatment for JIA patients with severe hip involvement and results in major improvements in pain and function. We did not identify any factors predictive of failure.

    View details for DOI 10.1016/j.arth.2023.12.021

    View details for PubMedID 38104785

  • Orthopaedic Injury Profiles in Methamphetamine Users: A Retrospective Observational Study. The Journal of the American Academy of Orthopaedic Surgeons Trasolini, N., Kang, H., Carney, J., Rounds, A., Murrietta, A., Marecek, G. S. 2020; 28 (1): e28-e33

    Abstract

    We sought to characterize the prevalence of methamphetamine (MA) abuse and associated orthopaedic injury patterns at our level 1 trauma center.We conducted a retrospective review of all orthopaedic consults for the year 2016. Patients were classified as MA users based on urine toxicology results and social history.The prevalence of MA use was 10.0%. MA users were more likely to present with hand lacerations and other infections (P < 0.05 for all). Regarding the mechanism of injury, MA users were more likely to be involved in automobile versus pedestrian, automobile versus bicycle, ballistic, knife, closed fist, other assault/altercation, and animal bite injuries (P < 0.05 for all).MA use is prevalent at our level 1 trauma center. The prevalence and injury patterns of MA abuse warrant deeper study into the effects of this drug on orthopaedic outcomes.Level III.

    View details for DOI 10.5435/JAAOS-D-18-00618

    View details for PubMedID 30985479